Further studies could also determine if the inhibitory effect of auranofin on thioredoxin reductase can induce redox-sensitive apoptosis of SARS-CoV-2-infected cells and if its anti-fibrotic action can prevent COVID-19-associated pulmonary fibrosis. Here, PRDX5 is linked to pulmonary fibrosis.